THC range is the middle half of 106 public lab tests of Blue Maui flower (2020–2022). Source: Cannlytics lab results, CC BY 4.0.
Blue Maui is a hybrid strain that comes from a cross of Blue Dream with Maui Wowie. People who try it most often describe feeling aroused, energetic and tingly.
Across 106 public lab tests of Blue Maui flower between 2020 and 2022, the median result was 23.8% total THC, with half of all samples falling between 22.2% and 24.9%. CBD is typically negligible (under 0.5%). That is in line with most flower on Canadian shelves. Potency varies by grower and batch, so always check the label.
In lab tests its dominant terpene is myrcene, followed by pinene and caryophyllene. Myrcene is known for earthy, musky notes with a ripe-fruit edge, while pinene adds sharp, fresh pine. Total terpene content measured a median of 2.2%. On the palate, people pick out apple.
Beyond feeling aroused, reviewers also mention feeling talkative and hungry. Some consumers say they reach for it when dealing with depression, pain and insomnia. The side effects mentioned most are dry mouth. These are personal reports, not medical advice.
Parents: Blue Dream and Maui Wowie.
Median share of flower weight in lab tests.
Matched on reported effects, terpenes and type.